ClinicalTrials.gg
CompletedNCT06998836Updated May 31, 2025

Constructing and Evaluating the Effectiveness of a Community-based Older Adults Dementia Prevention Education Program

An interventional study of Dementia prevention education and General Health Education Leaflet in Dementia, sponsored by Chang Gung University of Science and Technology. Completed at 1 site in Taiwan. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-31.

Sponsored by Chang Gung University of Science and Technology · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 5 months after the study started (first participant enrolled Dec 2023, registered May 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
142
Allocation
Not applicable
Ages
60 Years and older
Sex
All
01

Study summary

This study adopted a mixed-methods approach and was conducted in two exploratory phases. The first phase focused on development and involved three focus group interviews with community-dwelling older adults. These qualitative focus group discussions were used to inform the development of a dementia prevention education program based on the analysis results.

In the second phase, community-dwelling older adults were recruited to participate in the study. The experimental group received the dementia prevention education program, while the control group received general health education leaflets. Participants were assessed before the intervention, immediately after the intervention, and again three months later. The assessments measured changes in dementia-related knowledge, dementia-related worry, health beliefs, and willingness to engage in preventive actions.

This study aimed to examine the effects of the intervention on older adults' dementia knowledge, health beliefs, and willingness to undertake preventive actions.

02

Conditions studied

  • Dementia

Browse trials for

Keywords

  • dementia prevention
  • health beliefs
03

In context

Dementia

2,231 studies on the registry are indexed under Dementia; 549 are open to participants now.

This study's enrollment of 142 is above the median of 83 across 1,669 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

Chang Gung University of Science and Technology is the lead sponsor of 42 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: (1) 55 years old or above; (2) conscious and able to speak Mandarin and Taiwanese; and (3) willing to participate in this study and complete the consent form -

Exclusion Criteria:(1) diagnosed with dementia; or (2) diagnosed with severe physical or mental illness by a physician.

-

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
142 participants (actual)

Study arms

  • Experimental
    Intervention Group

    Participants received a structured dementia prevention education program based on focus group findings. The program included interactive sessions on dementia knowledge, risk reduction strategies, and health belief enhancement. Intervention(s): Dementia Prevention Education Program

    Behavioral: Dementia prevention education

  • Active comparator
    Control Group

    Participants received standard health education materials in leaflet form, covering general health maintenance topics not specific to dementia. Intervention(s): General Health Education Leaflet

    Other: General Health Education Leaflet

Interventions

  • BehavioralDementia prevention education

    Dementia prevention education:A structured dementia prevention education program developed based on qualitative focus group findings. The program includes multiple interactive sessions covering dementia knowledge, health beliefs, risk reduction strategies, and motivation for preventive actions.

  • OtherGeneral Health Education Leaflet

    Participants received printed general health education leaflets not specifically related to dementia. The content included general wellness and health maintenance advice.

06

What researchers measure

Primary outcomes

  1. Dementia Knowledge Score

    Measured using a validated dementia knowledge questionnaire. The score reflects the participant's understanding of dementia, including symptoms, risk factors, and prevention strategies.

    Time frame: Baseline, immediately post-intervention, 3-month follow-up

Secondary outcomes

  1. Dementia-Related Worry Score

    Measured using a standardized scale to assess the level of concern or fear participants feel toward developing dementia.

    Time frame: Baseline, immediately post-intervention, 3-month follow-up

07

Study locations

1 site
  • Chang Gung University of Science and Technology
    Taoyuan City, 333324, Taiwan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06998836
Lead sponsor
Chang Gung University of Science and Technology
Responsible party
Sponsor
First posted
May 31, 2025
Start date
Dec 1, 2023
Primary completion
Oct 30, 2024
Completion
Jan 13, 2025
Last update
May 31, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion